Little Feet Pediatric Therapy, a leading Washington DC pediatric speech therapy provider , is pleased to announce the publication of its newest report,“Speech Therapy for Excessive Drooling in ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

The Supreme Court heard arguments in a case that could strike down bans on so-called conversion therapy for children.

Bengaluru, India: Social media giant X warned on Monday that an Indian court allowed ruling police to issue “arbitrary” content removal orders through a government portal threatens free expression.

The House Judiciary Committee announced Tuesday that after extensive criticism and a couple of years of reflection, "Google commits to offer all creators previously kicked off YouTube due to political ...

The LNP | LancasterOnline Opinion department publishes reader letters in both the newspaper and online on Wednesdays and Sundays. On the other five days of the week (Monday, Tuesday, Thursday, Friday, ...

Many on Sartell’s Second Street might do a double-take when they pass by Sartell Pediatrics and see a big sign saying ...

Florida's Attorney General launched an online portal for the public to report violent speech. The portal was created in response to social media comments following the assassination of activist ...

Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.

President Donald Trump drew laughs from world leaders within moments of taking the stage at the United Nations General Assembly on Tuesday. Trump joked about a broken escalator in the UN building as ...

Opus Genetics has shared data on its gene therapy in children with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps for the program. North Carolina-based Opus ...